X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacology & pharmacy (13) 13
humans (8) 8
index medicus (8) 8
europe (7) 7
pharmacology (6) 6
dabigatran (4) 4
drugs (4) 4
enhance prescribing efficiency (4) 4
health care sciences & services (4) 4
health policy & services (4) 4
adaptive pathways (3) 3
care (3) 3
drug approval (3) 3
european union (3) 3
health care economics and organizations (3) 3
health policy (3) 3
health technology-assessment (3) 3
impact (3) 3
managed entry agreements (3) 3
marketing authorization (3) 3
medicines (3) 3
payers (3) 3
reimbursement (3) 3
analysis (2) 2
atrial-fibrillation (2) 2
cancer (2) 2
cancer drugs (2) 2
cost (2) 2
countries (2) 2
ema (2) 2
european countries (2) 2
future (2) 2
health aspects (2) 2
initiatives (2) 2
lithuania (2) 2
managed entry (2) 2
management (2) 2
marketing authorisation (2) 2
new models (2) 2
optimize (2) 2
original research (2) 2
orphan drugs (2) 2
pharmaceutical preparations - administration & dosage (2) 2
pharmaceuticals (2) 2
policies (2) 2
price (2) 2
rare diseases (2) 2
recommendations (2) 2
rheumatoid-arthritis (2) 2
therapeutics. pharmacology (2) 2
united-states (2) 2
abridged index medicus (1) 1
administrative databases (1) 1
administrative personnel (1) 1
adolescent (1) 1
agreements (1) 1
ambulatory care - economics (1) 1
ambulatory care - methods (1) 1
anti-bacterial agents (1) 1
antidepressants (1) 1
antimicrobial resistance (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
article (1) 1
articles (1) 1
availability (1) 1
bacteria (1) 1
bacteria - drug effects (1) 1
bacterial infections - drug therapy (1) 1
bacterial infections - microbiology (1) 1
bacterial infections - urine (1) 1
bacterial pneumonia (1) 1
biotechnology & applied microbiology (1) 1
blood-pressure (1) 1
bone marrow transplantation - adverse effects (1) 1
budget impact analysis (1) 1
bulgaria (1) 1
cardiovascular disease (1) 1
care and treatment (1) 1
case-history (1) 1
cee (1) 1
cells (1) 1
central and east europe (1) 1
child (1) 1
clerkship (1) 1
clinical pharmacology (1) 1
clinical trials, phase iii as topic (1) 1
co-payment (1) 1
commercial databases (1) 1
companies (1) 1
competences (1) 1
conditional approval (1) 1
consensus methods (1) 1
consumers (1) 1
cooperative behavior (1) 1
core curriculum (1) 1
critical drug evaluation (1) 1
cross border agreements (1) 1
databases, factual - statistics & numerical data (1) 1
decision making (1) 1
decision-making (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Review of Pharmacoeconomics & Outcomes Research, ISSN 1473-7167, 06/2011, Volume 11, Issue 3, pp. 343 - 349
Objectives: Assess whether European countries with smaller populations can obtain appreciable discounts for generics, similar to some of the larger European... 
reform | generics | population sizes | pharmaceutical pricing | REFORMS | PHARMACEUTICALS | ENHANCE PRESCRIBING EFFICIENCY | POLICIES | IMPACT | INITIATIVES | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | COMPANIES | Prices and rates | Generic drugs | Management | Pharmacists | Analysis | Health care reform
Journal Article
Medicina, ISSN 1010-660X, 2017, Volume 53, Issue 4, pp. 259 - 267
The aim of this ecological study was to evaluate whether any changes in cardiovascular (CV) medicine utilization, population, socioeconomic and health system... 
Cardiovascular disease | Medicine utilization | Mortality | Risk factors | METAANALYSIS | PREVENTION | BLOOD-PRESSURE | CARE | TRIAL | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | EUROPEAN COUNTRIES | UPDATE | HEALTH
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 01/2018, Volume 8, p. 942
Drug shortages have been identified as a public health problem in an increasing number of countries. This can negatively impact on the quality and efficiency... 
Health care system | Pharmaceutical policy | European Union | Organizational framework | Europe | Legislation | Western Asia | Drug shortage | UNITED-STATES | PATIENT-CARE | drug shortage | MEDICATIONS | FUTURE | ENHANCE PRESCRIBING EFFICIENCY | POLICIES | IMPACT | pharmaceutical policy | organizational framework | DEMAND-SIDE MEASURES | PHARMACOLOGY & PHARMACY | health care system | legislation
Journal Article
Frontiers in Public Health, ISSN 2296-2565, 12/2018, Volume 6, p. 328
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 01/2014, Volume 8, Issue 1, pp. 77 - 94
Journal Article
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 09/2016, Volume 7
Payers are a major stakeholder in any considerations and initiatives concerning adaptive licensing of new medicinal products, also referred to as Medicines... 
TRIALS | PRICE | Europe | MEDICINES SHARING EXPERIENCES | MANAGED ENTRY | adaptive pathways | payers | OPTIMIZE | DABIGATRAN | HEALTH TECHNOLOGY-ASSESSMENT | EMA | DRUG APPROVAL | PHARMACOLOGY & PHARMACY | marketing authorization | SURROGATE OUTCOMES
Journal Article
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 05/2019, Volume 10, p. 487
Background: Reimbursement policies influence access of patients to orphan drugs in the European countries. Objectives: To provide a comprehensive description... 
kappa coefficient of agreement | orphan drug | Central and East Europe | marketing authorisation | European Medicine Agency | PHARMACOLOGY & PHARMACY | reimbursement policy | conditional approval | exceptional circumstances | Decision-making | Surveys | Orphan drugs
Journal Article
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 2018, Volume 104, Issue 2, pp. 317 - 325
Harmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to ensure that the prescribing competency of future doctors is of a... 
IN-HOSPITAL INPATIENTS | CONSENSUS METHODS | CORE CURRICULUM | CLERKSHIP | PRESCRIBING ERRORS | PRECLINICAL MEDICAL-STUDENTS | INTERNAL-MEDICINE | COMPETENCES | PHARMACOLOGY & PHARMACY | DOCTORS | PROGRAM | Research
Journal Article